Peptidescience
SLU-PP-332 is a synthetic research peptide that has garnered significant attention for its potential to mimic the metabolic benefits of exercise. As a potent agonist of estrogen-related receptors (ERRs), particularly ERRα, this compound activates cellular pathways typically stimulated by endurance training. Research into SLU-PP-332 suggests its primary mechanism involves enhancing energy expenditure and promoting fat metabolism, leading to reduced fat mass accumulation and improved various metabolic functions. This peptide is a subject of ongoing scientific investigation, with studies exploring its role in energy regulation and metabolic health.A Synthetic ERR Agonist Alleviates Metabolic Syndrome - PMC
The core of SLU-PP-332's activity lies in its interaction with Estrogen-Related Receptors (ERRs)SLU-PP-332is a synthetic small-molecule compound examined in controlled laboratory and preclinicalresearchsystems as an agonist of estrogen-related receptor .... These receptors, which are structurally related to estrogen receptors but do not bind estrogen, play crucial roles in energy metabolism, mitochondrial function, and cellular respiration. SLU-PP-332 acts as a pan-ERR agonist, meaning it activates all three subtypes: ERRα, ERRβ, and ERRγ, with the strongest affinity for ERRα.Peptides act as signaling molecules, telling cells what to do. On the other hand, proteins have larger structural and metabolic roles. They ...
By activating ERRα, SLU-PP-332 is understood to:
* Increase Energy Expenditure: The peptide stimulates metabolic processes that burn more calories, similar to the effects of physical activity.
* Enhance Fat Oxidation: SLU-PP-332 promotes the breakdown of fatty acids for energy, contributing to a reduction in body fat.
* Improve Mitochondrial Function: It supports the efficiency of mitochondria, the powerhouses of cells, leading to better overall energy production and utilizationSLU-PP-332is aresearch peptidestudied for its potential role in energy regulation & metabolic function. Studies suggest it may influence fat metabolism..
* Mimic Endurance Training: Preclinical studies indicate that SLU-PP-332 can replicate some of the key physiological adaptations seen in endurance athletes, such as increased oxidative phosphorylation.SLU-PP-332 Peptide: Endurance, Fat Oxidation, and ...
These actions collectively contribute to a potential "exercise mimetic" effect, where the peptide offers some of the metabolic advantages of exercise without the physical exertion itselfMetabolic Health Studies:Investigates SLU-PP-332's effects on mitochondrial function and energy metabolism(MedChemExpress). Exercise Mimetic Research: ....
Much of the current understanding of SLU-PP-332's capabilities comes from preclinical research, primarily involving animal models.SLU-PP-332 is an emerging research compoundknown as “exercise in a pill,” mimicking key benefits of physical activity by enhancing metabolism, endurance, and ... These studies have revealed promising results regarding the peptide's impact on metabolic health and body composition.
Key findings from these research systems include:
* Reduced Fat Mass: In several mouse models of obesity, SLU-PP-332 has demonstrated an ability to significantly reduce body fat accumulation.SLU-PP-332 is a pan-ERRagonist, meaning it activates all three Estrogen-Related Receptors (ERRα, ERRβ, ERRγ). These receptors aren't related to estrogen ... Some studies report substantial body fat reduction percentages in treated animals.
* Improved Glucose Metabolism: Research suggests that SLU-PP-332 may also positively influence glucose homeostasis and insulin sensitivity, which are critical factors in managing metabolic syndrome and type 2 diabetesUmbrella Labs Introduces Research Use Only SLU PP 332 Program To ....
* Weight Management: Studies have shown that SLU-PP-332 can lead to notable weight loss in obese animal subjects, often by increasing metabolism rather than affecting appetite or food intake. For instance, some reports indicate that obese mice treated with SLU-PP-332 gained significantly less fat compared to untreated counterpartsA Synthetic ERR Agonist Alleviates Metabolic Syndrome - PMC.
* Enhanced Muscle Function: Beyond metabolic benefits, research is exploring SLU-PP-332's potential to boost muscle function and endurance at a cellular level, aligning with its exercise-mimicking properties2026年1月12日—What is SLU-PP-332? This peptide is classified as an exercise mimetic because itactivates pathways normally triggered by endurance training. It ....
It is crucial to emphasize that these findings are derived from laboratory and preclinical settings and do not directly translate to human efficacy or safetySLU-PP-332 (8112) by Tocris, Part of Bio-Techne. Further research is required to ascertain if these effects can be replicated and safely achieved in humans.
While the "exercise in a pill" analogy captures the imagination, the scientific utility of SLU-PP-332 extends to fundamental molecular and cellular researchMetabolic Health Studies:Investigates SLU-PP-332's effects on mitochondrial function and energy metabolism(MedChemExpress). Exercise Mimetic Research: .... Its specific action as an ERR agonist makes it a valuable tool for scientists investigating:
* Cellular Signaling Pathways: SLU-PP-332 helps researchers understand the intricate signaling cascades regulated by ERRs, providing insights into how cells manage energy and respond to metabolic cues.
* Mitochondrial Dynamics: The peptide is used to study the role of ERRs in regulating mitochondrial function, biogenesis, and overall cellular energy production.
* Metabolic Syndrome Research: Its potential to improve fat metabolism and glucose control makes it a compound of interest for exploring new therapeutic strategies for metabolic disorders.
The compound is typically supplied as a research-grade peptide, emphasizing its current status as a tool for scientific inquiry rather than a finished therapeutic product. Purity levels, often exceeding 99%, are critical for ensuring reliable experimental outcomes.
As a research compound, SLU-PP-332 is not approved for human consumption or therapeutic use by regulatory agencies. Its availability is primarily for laboratory and research purposesNew exercise mimetic drug SLU-PP-332made obese mice gain 10x less fat than untreated miceand lose 12% of their body weight by boosting the animals metabolism.. Discussions around its potential benefits, such as weight loss and metabolic improvement, are based on ongoing scientific explorationBuy SLU-PP-332 250mcg | 99% Purity (USA Made).
The development of SLU-PP-332 into a potential therapeutic agent would necessitate extensive clinical trials to establish its safety, efficacy, and optimal dosage in humans. Researchers continue to explore its mechanisms of action, potential side effects, and its place within the broader landscape of metabolic and exercise-related research.SLU-PP-332 isa compound which is a potent but non-selective estrogen-related receptor (ERR) agonist, acting most strongly at ERRα with an EC50 of 98 nM. The investigation into compounds like SLU-PP-332 highlights the growing interest in pharmacological interventions that can modulate metabolic health and potentially complement lifestyle interventions.
Join the newsletter to receive news, updates, new products and freebies in your inbox.